A Neil Pappalardo insider trades: Medical Information Technology (N) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where A reports to the SEC
Open-market buys and sales
39 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 10, 2018 | N | ↑ Buy | 2,200 | $45.00 | $99K | Direct | Sep 10, 2018 (0d) |
| May 23, 2018 | N | ↑ Buy | 13,000 | $45.00 | $585K | Direct | May 23, 2018 (0d) |
| Jul 19, 2017 | N | ↓ Sell | 34,000 | $44.00 | $1.5M | Direct | Jul 19, 2017 (0d) |
| Jun 8, 2017 | N | ↑ Buy | 34,000 | $44.00 | $1.5M | Direct | Jun 8, 2017 (0d) |
| Apr 30, 2015 | N | ↑ Buy | 217,391 | $45.00 | $9.8M | Direct | May 1, 2015 (1d) |
| Mar 18, 2014 | N | ↑ Buy | 200,000 | $9000000.00 | $1800.00B | Direct | Sep 26, 2014 (192d) |
| Jun 12, 2013 | PMTI | ↓ Sell | 15,000 | $13.45 | $202K | Direct | Jun 12, 2013 (0d) |
| Feb 15, 2013 | N | ↑ Buy | 25,000 | $1125000.00 | $28.13B | Direct | Feb 27, 2013 (12d) |
| Aug 30, 2012 | N | ↑ Buy | 350 | $15400.00 | $5.4M | Direct | Aug 31, 2012 (1d) |
| Feb 16, 2012 | N | ↑ Buy | 25,000 | $1075000.00 | $26.88B | Direct | Feb 17, 2012 (1d) |
| Dec 8, 2011 | N | ↑ Buy | 10,000 | $420000.00 | $4.20B | Direct | Dec 9, 2011 (1d) |
| Feb 28, 2011 | N | ↑ Buy | 25,000 | $100000.00 | $2.50B | Direct | Mar 1, 2011 (1d) |
| Aug 9, 2010 | N | ↑ Buy | 720 | $27360.00 | $19.7M | Direct | Sep 1, 2010 (23d) |
| Feb 25, 2010 | N | ↑ Buy | 25,000 | $925000.00 | $23.13B | Direct | Mar 1, 2010 (4d) |
| Dec 10, 2009 | N | ↑ Buy | 150 | $5550.00 | $833K | Direct | Dec 31, 2009 (21d) |
| Nov 17, 2009 | N | ↑ Buy | 755 | $27935.00 | $21.1M | Direct | Nov 30, 2009 (13d) |
| Oct 29, 2009 | N | ↑ Buy | 1,815 | $57594.12 | $104.5M | Direct | Oct 30, 2009 (1d) |
| Oct 8, 2009 | N | ↑ Buy | 480 | $17760.00 | $8.5M | Direct | Oct 30, 2009 (22d) |
| Sep 28, 2009 | N | ↑ Buy | 1,740 | $31827.44 | $55.4M | Direct | Sep 30, 2009 (2d) |
| Sep 18, 2009 | N | ↑ Buy | 350 | $12950.00 | $4.5M | Direct | Sep 30, 2009 (12d) |
| Aug 6, 2009 | N | ↑ Buy | 1,460 | $36822.60 | $53.8M | Direct | Aug 31, 2009 (25d) |
| Jul 28, 2009 | N | ↑ Buy | 2,225 | $56258.71 | $125.2M | Direct | Jul 31, 2009 (3d) |
| Jun 17, 2009 | N | ↑ Buy | 2,030 | $75110.00 | $152.5M | Direct | Jul 2, 2009 (15d) |
| May 22, 2009 | N | ↑ Buy | 2,405 | $30223.46 | $72.7M | Direct | May 29, 2009 (7d) |
| Apr 28, 2009 | N | ↑ Buy | 6,603 | $141139.11 | $931.9M | Direct | Apr 30, 2009 (2d) |
| Mar 26, 2009 | N | ↑ Buy | 33,085 | $655218.70 | $21.68B | Direct | Mar 26, 2009 (0d) |
| Feb 9, 2009 | N | ↑ Buy | 2,300 | $78021.74 | $179.4M | Direct | Feb 27, 2009 (18d) |
| Dec 19, 2008 | N | ↑ Buy | 445 | $9688.60 | $4.3M | Direct | Dec 31, 2008 (12d) |
| Nov 26, 2008 | N | ↑ Buy | 2,150 | $59135.47 | $127.1M | Direct | Nov 26, 2008 (0d) |
| Oct 28, 2008 | N | ↑ Buy | 2,175 | $43560.06 | $94.7M | Direct | Oct 31, 2008 (3d) |
| Oct 14, 2008 | N | ↑ Buy | 225 | $8325.00 | $1.9M | Direct | Oct 31, 2008 (17d) |
| Mar 21, 2008 | N | ↓ Sell | 400 | $14800.00 | $5.9M | Direct | Mar 25, 2008 (4d) |
| Feb 28, 2008 | N | ↑ Buy | 25,000 | $925000.00 | $23.13B | Direct | Feb 29, 2008 (1d) |
| Apr 6, 2007 | N | ↓ Sell | 1,000 | $35000.00 | $35.0M | Direct | Apr 6, 2007 (0d) |
| Feb 28, 2007 | N | ↓ Sell | 1,000 | $35000.00 | $35.0M | Direct | Feb 28, 2007 (0d) |
| Feb 27, 2007 | N | ↑ Buy | 25,000 | $875000.00 | $21.88B | Direct | Feb 28, 2007 (1d) |
| Mar 14, 2006 | N | ↑ Buy | 225,000 | $3022222.22 | $680.00B | Direct | Mar 14, 2006 (0d) |
| Mar 14, 2006 | N | ↑ Buy | 100,000 | $3300000.00 | $330.00B | Direct | Mar 14, 2006 (0d) |
| Mar 13, 2006 | N | ↓ Sell | 5,700 | $63382.46 | $361.3M | Direct | Mar 14, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About A Neil Pappalardo's insider trades
A Neil Pappalardo is Chairman at Medical Information Technology (N). Since Mar 13, 2006, A has reported 33 open-market purchases worth $2963.48B and 6 sales worth $438.9M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (7 filings), option exercises (4 filings), shares returned to the company (1 filing), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every N insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.